Study reveals biomarkers that predict disability worsening in multiple sclerosis

Medical Xpress

High Factuality

Key biomarkers identified for predicting disability progression in multiple sclerosis

A study presented at ECTRIMS 2024 has identified critical biomarkers that can predict disability worsening in multiple sclerosis (MS). The breakthrough research has the potential to transform treatment strategies for millions of MS patients worldwide, paving the way for more personalized and effective treatment plans.